Literature DB >> 25112800

Hemoglobin, iron metabolism and angiographic coronary artery disease (The Ludwigshafen Risk and Cardiovascular Health Study).

Tanja B Grammer1, Marcus E Kleber2, Günther Silbernagel3, Stefan Pilz4, Hubert Scharnagl5, Andreas Tomaschitz6, Wolfgang König7, Winfried März8.   

Abstract

BACKGROUND: Anemia has been shown to be a risk factor for coronary artery disease and mortality. The involvement of body iron stores in the development of CAD remains controversial. So far, studies that examined hemoglobin and parameters of iron metabolism simultaneously do not exist. METHODS AND
RESULTS: Hemoglobin and iron status were determined in 1480 patients with stable angiographic coronary artery disease (CAD) and in 682 individuals in whom CAD had been ruled out by angiography. The multivariate adjusted odds ratios (OR) for CAD in the lowest quartiles of hemoglobin and iron were 1.62 (95%CI: 1.22-2.16), and 2.05 (95%CI: 1.51-2.78), respectively compared to their highest gender-specific quartiles. The fully adjusted ORs for CAD in the lowest quartiles of transferrin saturation, ferritin (F) and soluble transferrin receptor (sTfR)/log10F index were 1.69 (95%CI: 1.25-2.27), 1.98 (95%CI: 1.48-2.65), and 1.64 (95%CI: 1.23-2.18), respectively compared to their highest gender-specific quartiles. When adjusting in addition for iron and ferritin the OR for CAD in the lowest quartiles of hemoglobin was still 1.40 (95%CI: 1.04-1.90) compared to the highest gender-specific quartiles. Thus, the associations between either iron status or low hemoglobin and CAD appeared independent from each other. The sTfR was only marginally associated with angiographic CAD.
CONCLUSIONS: Both low hemoglobin and iron depletion are independently associated with angiographic CAD.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Coronary artery disease; Ferritin; Hemoglobin; Iron; Soluble transferrin receptor; Transferrin saturation

Mesh:

Substances:

Year:  2014        PMID: 25112800     DOI: 10.1016/j.atherosclerosis.2014.07.002

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  17 in total

Review 1.  Iron deficiency and cardiovascular disease.

Authors:  Stephan von Haehling; Ewa A Jankowska; Dirk J van Veldhuisen; Piotr Ponikowski; Stefan D Anker
Journal:  Nat Rev Cardiol       Date:  2015-07-21       Impact factor: 32.419

2.  Relevance of pre-existing anaemia for patients admitted for acute coronary syndrome to an intensive care unit: a retrospective cohort analysis of 7418 patients.

Authors:  Patricia Wischmann; Raphael Romano Bruno; Bernhard Wernly; Georg Wolff; Shazia Afzal; Richard Rezar; Mareike Cramer; Nadia Heramvand; Malte Kelm; Christian Jung
Journal:  Eur Heart J Open       Date:  2022-06-15

Review 3.  Is Correction of Iron Deficiency a New Addition to the Treatment of the Heart Failure?

Authors:  Donald S Silverberg; Dov Wexler; Doron Schwartz
Journal:  Int J Mol Sci       Date:  2015-06-18       Impact factor: 5.923

Review 4.  The Prognostic Role of Red Blood Cell Distribution Width in Coronary Artery Disease: A Review of the Pathophysiology.

Authors:  Kamil Bujak; Jarosław Wasilewski; Tadeusz Osadnik; Sandra Jonczyk; Aleksandra Kołodziejska; Marek Gierlotka; Mariusz Gąsior
Journal:  Dis Markers       Date:  2015-08-26       Impact factor: 3.434

5.  The association of ferritin with cardiovascular and all-cause mortality in community-dwellers: The English longitudinal study of ageing.

Authors:  Nikolaos P E Kadoglou; Jane P Biddulph; Snorri B Rafnsson; Marialena Trivella; Petros Nihoyannopoulos; Panayotes Demakakos
Journal:  PLoS One       Date:  2017-06-07       Impact factor: 3.240

6.  Prevalence and prognostic implication of iron deficiency and anaemia in patients with severe aortic stenosis.

Authors:  Anette Borger Kvaslerud; Amjad Iqbal Hussain; Andreas Auensen; Thor Ueland; Annika E Michelsen; Kjell Ingar Pettersen; Pål Aukrust; Lars Mørkrid; Lars Gullestad; Kaspar Broch
Journal:  Open Heart       Date:  2018-12-16

7.  Effects of Genetically Determined Iron Status on Risk of Venous Thromboembolism and Carotid Atherosclerotic Disease: A Mendelian Randomization Study.

Authors:  Dipender Gill; Christopher F Brewer; Grace Monori; David-Alexandre Trégouët; Nora Franceschini; Claudia Giambartolomei; Ioanna Tzoulaki; Abbas Dehghan
Journal:  J Am Heart Assoc       Date:  2019-07-16       Impact factor: 5.501

8.  Iron and hepcidin as risk factors in atherosclerosis: what do the genes say?

Authors:  Tessel E Galesloot; Luc L Janss; Stephen Burgess; Lambertus A L M Kiemeney; Martin den Heijer; Jacqueline de Graaf; Suzanne Holewijn; Beben Benyamin; John B Whitfield; Dorine W Swinkels; Sita H Vermeulen
Journal:  BMC Genet       Date:  2015-07-11       Impact factor: 2.797

9.  Correlations of DAPT score and PRECISE-DAPT score with the extent of coronary stenosis in acute coronary syndrome.

Authors:  Tianyi Long; Liming Peng; Fei Li; Ke Xia; Ran Jing; Xiangwei Liu; Qiying Xie; Tianlun Yang; Chenglong Zhang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

10.  Adverse Outcome Prediction of Iron Deficiency in Patients with Acute Coronary Syndrome.

Authors:  Tanja Zeller; Christoph Waldeyer; Francisco Ojeda; Renate B Schnabel; Sarina Schäfer; Alev Altay; Karl J Lackner; Stefan D Anker; Dirk Westermann; Stefan Blankenberg; Mahir Karakas
Journal:  Biomolecules       Date:  2018-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.